INTRODUCTION
Vascular endothelial cells secrete vasoactive substances such as prostacyclin (PGI2) [1] , endothelium-derived relaxing factor(s) (EDRF) [2] , and endothelin [3] , which play an important role in the regulation of vascular tone. PGI2 synthesized by the vascular wall is a potent vasodilator and an inhibitor of platelet adhesion and aggregation that contributes to the maintenance of vascular wall homoeostasis. However, the detailed mechanisms of the regulation of PGI2 production by the vascular wall have not yet been clarified. Recently, Yui et al. [4] reported that apolipoprotein A-1, a major component of high-density-lipoprotein cholesterol, was responsible for PGI2-stabilizing factor. Maclntyre et al. [5] demonstrated that human plasma stimulated PGI2 production by cultured aortic endothelial cells. This stimulating activity of plasma may be crucial in the regulation of PGI2 production by the vascular wall. Remuzzi et al. [6] also reported that this activity in plasma was reduced in patients with haemolyticuraemic syndrome. In our previous studies, we found that the ability of plasma to stimulate PGI2 production was reduced in patients with diabetes mellitus and reported that this activity came from relatively heat-stable, acid-labile and non-dialysable factors [7, 8] . Then we found that the conditioned medium from cultured human diploid fibroblast cells also contains an activity to stimulate PGI2 production [9] . Characterization of this activity in the conditioned medium from human diploid fibroblast cells revealed that the properties were similar to that of human plasma-derived serum, e.g. relatively heat-stable, acid-labile, trypsin-sensitive, and possessing an affinity for heparin [9] . Although many substances that stimulate PGI2 production by vascular endothelial cells have been identified [10] [11] [12] [13] [14] [15] [16] , none of these substances seems to correspond to the PGI2-stimulating activity in question. The present study was, therefore, undertaken to purify and clone this PGI2-stimulating factor (PSF) from the conditioned medium of cultured human diploid fibroblast cells.
sharp peak in 31 % (v/v) acetonitrile. The material was purified 8000-fold with an overall yield of about 18 %. The purified PSF stimulated PGI2 production by cultured bovine aortic endothelial cells at a concentration of about 10 ng/ml; maximal stimulation was achieved at a concentration of 25 ng/ml. A cDNA coding for PSF was cloned and sequenced, revealing an apparently novel protein with no obvious sequence similarity to known proteins.
MATERIALS AND METHODS Assay of PSF activity
Bovine aortic endothelial cells were cultured as previously described [7, 8, 16] . Briefly, endothelial cells were scraped off the intimas of bovine thoracic aortas and cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco Laboratories, Grand Island, NY, U.S.A.) containing 10 % (v/v) heat-inactivated fetal-calf serum (FCS) (Gibco), 100 units/ml penicillin and 100 ,ug/ml streptomycin at 37°C in an atmosphere consisting of 5 % CO2/95 % air. The medium was replaced every 3 days. The cultured cells showed a 'cobblestoned' appearance by phasecontrast microscopy and produced von Willebrand factor and endothelin-I [17, 18] , indicating that they were vascular endothelial cells. When the cells reached confluence, they were subcultured with 0.05 % (w/v) trypsin solution. The cells were harvested from the fifth to tenth passages by trypsinization and placed in a 24-well multidish in a concentration of 1.5 x 104 cells/well in 1 ml of DMEM containing 10 % (v/v) FCS. When the endothelial cells reached confluence (1.0 x 105 cells/well), the medium was removed and test solutions were added to the wells. After 60 min of incubation, the test solution was collected and assayed for accumulated concentration of 6-keto-prostaglandin Fla (6-keto-PGF1.) by radioimmunoassay (r.i.a.), as previously described [7, 8] DEAE-5PW h.p.l.c. Concentrated conditioned medium (50 ml) was pumped on to a DEAE-5PW column (25 mm x 150 mm, Toyo-Soda, Tokyo, Japan) pre-equilibrated with 20 mM Tris/HCl (pH 7.8) at a speed of 2 ml/min. The column was then washed with 500 ml of equilibration solvent and eluted at a flow rate of 6 ml/min with a linear gradient of 0-1 M NaCl in 20 mM Tris/HCl (pH 7.8).
The absorbance of the column effluent was monitored at 280 nm. Fractions of 3 ml were collected and used for the PSF assay.
Heparin-5PW h.p.l.c.
The active fractions obtained from DEAE-SPW chromatography were collected and dialysed against 10 mM phosphate buffer (PB; pH 7.4). The sample was loaded on to a Heparin-SPW column (7.5 mm x 75 mm, Toyo-Soda) pre-equilibrated with 10 mM PB (pH 7.4). The column was washed with 20 ml of preequilibration buffer and then eluted at a flow rate of 1 ml/min with a linear gradient of 0-1 M NaCl in 10 10 mM PBS containing 0.5 M NaCl (pH 7.4), 0.5 M acetic acid (pH 3.0), and finally 10 mM PBS (pH 7.4). The gel was applied to a column (HR 10/10, Pharmacia P-L, Uppsala, Sweden) attached to the h.p.l.c. system, and chromatography was performed. Active fractions derived from the Protein-Pak 300 gel chromatography were applied to an IGF-1 ligand affinity column, pre-equilibrated with 10 mM PB (pH 7.4), and eluted with 0.5 M acetic acid (pH 3.0) at a flow rate of 1 ml/min. The absorbance of the column effluent was monitored at 280 nm. One millilitre flow-through fractions and eluted fractions were collected. Eluted fractions were neutralized immediately with 5 M sodium acetate to pH 6.5, and dialysed against PBS (pH 7.4). These samples were used for the PSF assay.
SDS/PAGE SDS/PAGE was performed according to the method described by Laemmli [19] . Samples were heated (95°C, 3 min) and applied to a gradient gel consisting of 5-20% polyacrylamide. After electrophoresis, the gel was fixed with 40 % (v/v) methanol/lO % (v/v) acetic acid and stained with silver [20] . Low-molecularmass markers (Bio-Rad) consisted of phosphorylase b (97400 Da), BSA (66200 Da), ovalbumin (42699 Da), carbonic anhydrase (31000 Da), soybean trypsin inhibitor (21 500 Da), and lysozyme (14400 Da).
Protein determination
The protein concentration was estimated using a protein assay kit (Bio-Rad), with BSA (Bio-Rad) as a standard.
Amino acid analysis Purified protein was desalted by being dialysed against distilled water and lyophilized using a Speed-Vac concentrator (Savant Instruments, Hicksville, NY, U.S.A.). Peptides were generated by cleavage with trypsin (Boehringer-Mannheim GmbH, Mannheim, Germany) and incubated at 37°C for 16 h. Peptide mixtures were purified by reversed-phase h.p.l.c. on a Vydac C8 column (The Separations Group, Hesperia, CA, U.S.A.). Amino acid sequences of resulting peptides were determined by automated Edman degradation using an Applied Biosystems Model 477A protein sequencer with an on-line Model 120A analyser.
Construction of the cDNA library Total RNA was extracted from cultured human diploid fibroblast cells by the acid guadinium thiocyanate-phenol-chloroform method [21] and poly(A)+ RNA was isolated using oligo(dT)-cellulose (Pharmacia LKB Biotechnology AB, Uppsala, Sweden) column. Oligo(dT)-primed and random-primed double-stranded cDNAs were prepared using cDNA Synthesis System Plus (Amersham International, Amersham, Bucks., U.K.) according to the method described by Gubler and Hoffman [22] with some modification. Then a BstXI non-palindromic adapter was ligated to the oligo(dT)-primed cDNA. The cDNA fragments longer than 500 bp were isolated by preparative agarose gel electrophoresis, and then ligated into BstXI-digested pEF-BOS vector [23] . Escherichia coli MC1061/p3 cells were transformed with the resulting plasmids by electroporation [24] , yielding approx. 6.0 x 10 independent recombinant clones. For the construction of the random-primed cDNA library, non-phosphorylated EcoRI/BamHI/KpnI/NcoI adapter was ligated to the cDNA and low-molecular-mass materials were removed by passage over an NIP5 17 column (Amersham). After phosphorylation, the cDNA were ligated into the EcoRI arms of AgtlO (Amersham), followed by in vitro packaging (Gigapack II Packaging Extract, Stratagene, La Jolla, CA, U.S.A.). A library of approx. 6.0 x 105 independent recombinant clones was obtained. AA/GC/TTCXGCXCCc/TTCXCCc/TTT-3') where X denotes all four deoxynucleotides. Oligo(dT)-primed first-strand cDNA was synthesized by Superscript Preamplification System (Life Technologies, Gaithersburg, MD, U.S.A.) using the poly(A)+ RNA from the human diploid fibroblast cells, and then subjected to 30 cycles of PCR amplification with the degenerate primers. Primerdirected extension was repeatedly carried out by serial cycles of denaturation (1 min at 94°C), annealing (2 min at 55°C) and polymerization (3 min at 72°C). A generated fragment was sequenced and a pair of primers for the following PCR-based screening was then designed.
To obtain full-length PSF cDNA, two kinds of libraries, the oligo(dT)-primed cDNA library in pEF-BOS and the randomprimed cDNA library in AgtlO, were screened. Approx. 6.0 x 105 recombinant clones from the pEF-BOS cDNA library in E. coli MC1061/P3 were plated (1.4 x 104 clones each). The plasmid DNAs were prepared, digested with XbaI and subjected to 30 cycles of PCR amplification with the PCR-based screening primers. Primer-directed extension was repeatedly carried out by serial cycles of denaturation (30 s at 94°C), annealing (30 s at 55°C), and polymerization (1 min at 72°C). The AgtlO cDNA library was screened using the radiolabelled PvuII/SmaI fragment of the cDNA obtained from a positive clone in the pEF-BOS cDNA library. Plaque hybridization was performed overnight on nylon filters at 42°C in a hybridization solution containing 6 x SSPE (SSPE: 0.15 M NaCl/lOmM NaH2PO4/ 1 mM EDTA, pH 7.4), 1 x Denhardt's, 50 % formamide, 10 % (w/v) dextran sulphate, 100 ,ug/ml denatured salmon sperm DNA, 0.1 % SDS and 1 x 0I c.p.m./ml of the labelled probe. The filters were washed with 0.1 x SSC (SSC: 0.15 M NaCl/ 0.015 M sodium citrate) containing 0.1 % SDS at 44°C for 1 h.
The cDNA inserts were isolated from the phage purified from positive plaques, and subcloned into pUC vector for nucleotide sequencing.
Viability of cultured bovine aortic endothelial cells
Cultured bovine aortic endothelial cells were stimulated by PSF partially purified by a DEAE-SPW anion-exchange column for 60 min. Lactic dehydrogenase activity in the medium was measured by the method of Wroblewski and LaDue [25] with some modification and a number of the cells that excluded Trypan Blue solution was counted by light microscopy.
[3H]Thymidine Incorporation into cultured bovine aortic endothelial cells After stimulation with partially purified PSF, the medium was removed and the cells were further incubated with DMEM containing methyl-[3H]thymidine (0.25 ,uCi/ml, specific radioactivity 20 Ci/mmol) for 4 h at 37 'C. The cells were washed with PB (pH 7.4), lysed by 1 M NaOH and the radioactivity incorporated into the cells was measured by a liquid-scintillation counter [26] .
Western-blot analysis of PSF in human serum and conditioned medium from human diploid fibroblast cells Polyclonal antibodies against PSF were raised in rabbits by multiple intracutaneous injections of authentic 12 amino acids corresponding to the C-terminal of PSF in Freund's adjuvant. Two weeks after the last immunization blood was collected and anti-PSF antibody was prepared. For Western-blot analysis, samples of conditioned medium from human diploid fibroblast cells and human serum (20 
RESULTS
Purfflcation of PSF The purification of PSF was performed using the concentrated serum-free conditioned medium of human diploid fibroblast cells. We found that the PSF in this conditioned medium resides in an acid-labile, trypsin-sensitive, anionic, and heparin-binding factor with an apparent molecular mass of 30000 Da by gelfiltration chromatography [9] . Using these characteristics of PSF, a purification scheme was designed. The concentrated medium was first subjected to anion-exchange h.p.l.c. on a DEAE-5PW column. The bulk of the PSF activity bound to this column and a single PSF activity peak was eluted between 50 and 150 mM NaCl (Figure la) , resulting in an 8-fold increase in specific activity, and a calculated recovery of 49 % (Table 1) . No PGI2-stimulating activity was detected in the fractions above 150 mM NaCl. In this purification step, we examined the kinetics and dose dependency of PGI2 production. The PSF partially purified by the DEAE-SPW column significantly stimulated 6- dose-response curve of 6-keto-PGF,, pro- (Figure 2) . The methacin completely inhibited the 6-keto-PGF1. production Lction was induced by stimulated with the partially purified PSF. Purification and molecular cloning of prostacyclin-stimulating factor As the next step, the pooled active fractions obtained from the DEAE-5PW column were injected into a Heparin-5PW column. Much protein with undetectable PSF activity was passed through the column, and a single peak of PSF activity was eluted between 450 and 500 mM NaCl (Figure lb) . The biologically specific activity of PSF increased by a further 2.5-fold, with a recovery of 25 % (Table 1 ). Then h.p.l.c. was performed on a Protein-Pak 300 column for further purification, and a single peak of PSF activity was detected at a position corresponding to a molecular mass of 29 kDa (Figure 3a ), leading to a further 100-fold purification with 21 % recovery ( Table 1) . Analysis of the protein composition of biologically active fractions of PSF from the Protein-Pak 300 gel chromatography by SDS/PAGE and silver staining showed that PSF migrated as a single band in a position corresponding to a molecular mass of 31 kDa under non-reduced conditions (Figure 3b) .
In order to determine the purity of PSF, the active fractions (retention times 22 and 23 min) from the Protein-Pak 300 gel chromatography were subjected to C4 reversed-phase h.p.l.c.
Two major peaks of protein were eluted; one at 280% concentration of acetonitrile (fraction I) and the other at 31 % acetonitrile (fraction II) (Figure 4a) . No PSF activity was recovered from these fractions because acetonitrile or low pH 6 Analysis of SOS/PAGE and silver staining of the purHied PSF inactivated the biological activity of the PSF. However, the Nterminal ends of the proteins isolated from the C4 column could be analysed. Fraction I yielded a single N-terminal amino acid sequence, RAPGPGQGVQAGAPG, which is nearly identical with the N-terminal sequence of the insulin-like growth factorbinding proteins (IGFBPs) purified from human cerebrospinal fluid [27] , human transformed fibroblast cells [28] and human serum [29] .
Final purification was therefore achieved by an IGF-1 ligand affinity column. PSF activity was detected in flow-through fractions of the IGF-I ligand affinity chromatography, but not in the fractions eluted with 0.5 M acetic acid (Figure 4b) . Flow- through fractions applied to a C4 column showed a single protein peak at 31 % acetonitrile (Figure 5a ), and eluted fractions showed a peak at 28 % acetonitrile ( Figure Sb) . In this step, the biological activity of PSF increased 4-fold, with a recovery of 18 %. SDS/PAGE showed that PSF migrated with apparent molecular mass of 31 kDa under non-reduced conditions ( Figure  6 ). Dose-dependent effects of PSF at each purification step on 6-keto-PGF1l production by cultured bovine aortic endothelial cells are shown in Figure 7 . Table 1 summarizes the results of the purification steps performed with 52.35 mg of protein of serumfree conditioned medium from human diploid fibroblast cells. The overall increase in specific activity of PSF was about 8000-fold, with a recovery of 18 %. The purified PSF was digested with trypsin and the resulting polypeptides were separated by reversed-phase h.p.l.c. on a Vydac C8 column. Major peaks on the C8 column were subjected to amino-acid-sequence analysis, revealing amino acid sequences of ITVVDALHEIPVKKGEGAEL (peptide 1), GHYGVQR (peptide 2), and TELLPGDRDNLAIQTR (peptide 3). The information on the sequence of peptide 1 was used in following experiments to clone the PSF cDNA.
cONA cloning
To isolate cDNA encoding PSF, we first performed RT-PCR with a pair of degenerate primers as described in the Materials and methods section, generating a 59-bp fragment (5'-ATTACGGTGGTTGATGCGTTACATGAAATACCAGTG-AAAAAAGGCGAAGGCGCCGAATT-3'). The amino acid sequence deduced from the nucleotide sequence of this fragment agreed absolutely with that of peptide 1, one of the peptide fragments derived from purified PSF. We subsequently synthesized a pair of PCR primers (5'-TTGATGCGTTACAT-GAAATA-3', 5'-CCTTCGCCTTTTTTCACTGG-3'), both of which are parts of the 59-bp fragment, to screen the human diploid fibroblast-derived oligo(dT)-primed cDNA library in pEF-BOS. We examined 46 pools, each of which contained approx. 1.4 x 104 clones, and detected the expected PCR product in 27 pools. Two of them were subpooled and then screened again with the PCR, yielding two positive clones named pM950 and pM95 1 which have 557-bp and 802-bp cDNA inserts 1 4 1 GCC6CTGCCACC6CACCCCSCCAT66A6C66CCGTCSCT6C6CKCCCTSCTCCTC66CIC respectively. The deduced amino acid sequence from the nucleotide sequences of pM950 and pM951 cDNA inserts contained regions which correspond to the sequence of the three peptide fragments obtained from purified PSF, although neither has an in-frame initiation codon.
With a PvuII/SmaI fragment of pM951 cDNA insert as a probe, we then screened a random-primed cDNA library in AgtI 0 and isolated eight positive cDNA clones. One clone, named pM952, has a 11 24-bp cDNA insert containing an open reading frame which codes 282 amino acids from the putative first methionine with a potential N-glycosylation site at position 171 (Figure 8) . Analysis of the hydrophobicity of the deduced amino acid sequence predicts that a hydrophobic stretch of the N-terminal region is a signal peptide. 21 .5 Figure 9 Western-blot analysis of PSF in human serum and the conditioned medium from human diploid fibroblast cells Samples (20 /lg) of protein from human serum and conditioned medium from fibroblast cells were prepared for the sample as described in the Materials and methods section. Molecularmass markers are indicated by the arrows. CM: conditioned medium of human diploid fibroblast cells.
To examine the presence of the PSF in human serum, we prepared anti-PSF polyclonal antibody. Immunoblot analysis using this antibody showed that the human serum contained the PSF whose molecular mass was the same as that of conditioned medium from human diploid fibroblast cells (Figure 9 ).
DISCUSSION
The present study demonstrates that the PSF purified from serum-free conditioned medium of cultured human diploid fibroblast cells was an acid-labile and anionic protein, with a molecular mass of approx. 31 kDa on SDS/PAGE. Further significant characterization of PSF was that the factor had a marked affinity for heparin. A number of other growth factors have shown an affinity for heparin, such as capillary endothelial cell growth factor derived from chondrosarcoma [30] , fibroblast growth factor from brain and pituitary gland [31] , endothelial cell growth factor from bovine brain tissue [32] , cartilage-derived growth factor from bovine scapular cartilage [33] , and hepatocyte growth factor from rat platelets [34] . Previous studies have shown that the plasma-derived PGI2-stimulating activity is inhibited by the addition of heparin [35, 36] . Therefore, we decided to use heparin as a ligand for affinity chromatography to purify PSF. The results show that the affinity of PSF for heparin greatly facilitated the purification process of this factor.
A number of biologically active peptides and proteins have been isolated from serum-free culture medium from various cell lines. IGFBP-4 has been purified from culture medium conditioned by Simian virus 40-transformed human fibroblast cells [28] . More recently, IGFBP-4 was isolated from adult human serum by ligand affinity chromatography with IGF-1, and its cDNA was cloned [29] . In the present study, analysis of the Nterminal sequence of the fractions obtained from C4 reversedphase h.p.l.c. showed that the serum-free conditioned medium of Many substances, including arachidonic acid, ionophore A23187, phorbol ester [10] , platelet-derived growth factor [11] , interleukin 1 [12] , tumour necrosis factor [13] , epidermal growth factor [14] and transforming growth factor [15] , have been found to stimulate PGI2 production by cultured vascular endothelial cells. However, the chemical properties of PSF purified from serum-free conditioned medium of human diploid fibroblast cells differ from the properties of these substances. Arachidonic acid, A23187, and phorbol ester cause rapid stimulation of PGI2 production; the remaining substances cause a delayed stimulation of PGI2 production. PSF also caused rapid stimulation of PGI2 production. The stimulation of PGI2 production by PSF was completely inhibited by pre-incubation of endothelial cells with indomethacin. These results suggest that the PGI2 stimulation by PSF is caused by the activation of enzymes in the arachidonic, acid cascades. The kinetics of PGI2 production stimulated by the partially purified PSF was somewhat different from that by human serum. 6-Keto-PGF1, production stimulated by human serum reached a maximum extent faster (10 min) than that stimulated by partially purified PSF (60 min). Furthermore, a maximum extent of 6-keto-PGF1. production by partially purified PSF was greater than that by human serum [8] . These differences may be explained by the existence of many substances that affect PGI2 production in serum. A computer search of the May 1993 edition of the GenBank database for sequences show no similarity between the PSF and any other known proteins, suggesting that PSF is a novel factor.
We previously detected the presence of PG12-stimulating activity in human plasma-derived serum and found that this activity was reduced in patients with non-insulin-dependent diabetes mellitus and in streptozotocin-induced diabetic rats [7, 8] . This circulating activity for PGI2 production has also been found to be reduced in thromboembolic disorders, such as the haemolytic-uraemic syndrome [6] , thrombotic thrombocytopenic purpura [37] , sickle cell anaemia [38, 39] and acute myocardial infarction [40] . Our results indicate that the PSF purified from human diploid fibroblast cells is also present in human serum. However, it remains to be verified as to how much PSF in plasma contributes to the PGI2 production by vascular endothelial cells in vivo because many factors in plasma have been reported already to stimulate PGI2 production as mentioned above. Expression of PSF in appropriate cell systems should allow isolation of sufficient amounts of pure material to perform further studies on the actions of PSF in vitro and in vivo.
In conclusion, we have confirmed the presence of the PGI2-stimulating activity in the conditioned medium ofcultured human diploid fibroblast cells, and succeeded in the complete purification and molecular cloning of the novel factor corresponding to this activity.
This work was supported by a Grant-in-Aid for Scientific Research (No. 04671487) from the Ministry of Education, Science and Culture, Japan.
